The 2024 APLAR consensus on the management of lupus nephritis
International Journal of Rheumatic Diseases; 28:e70021 DOI: 10.1111/1756-185X.70021
Mok et al. provided updated consensus recommendations from APLAR, emphasising evidence-based guidance for managing lupus nephritis in Asian populations. These recommendations consider ethnic, socioeconomic, and pharmacogenetic factors, focusing on treatment regimens, adjunctive therapies, and patient-specific approaches to optimise outcomes.
The study aimed to update management strategies for lupus nephritis, incorporating two novel therapies and feedback from Delphi exercises. It sought to address disparities in outcomes due to genetic, cultural, and healthcare system variations in the Asia-Pacific region.
